Literature DB >> 27720794

Mindfulness-Based Stress Reduction in Post-treatment Breast Cancer Patients: Immediate and Sustained Effects Across Multiple Symptom Clusters.

Richard R Reich1, Cecile A Lengacher2, Carissa B Alinat2, Kevin E Kip2, Carly Paterson2, Sophia Ramesar2, Heather S Han3, Roohi Ismail-Khan3, Versie Johnson-Mallard4, Manolete Moscoso2, Pinky Budhrani-Shani5, Steve Shivers6, Charles E Cox7, Matthew Goodman8, Jong Park9.   

Abstract

CONTEXT: Breast cancer survivors (BCS) face adverse physical and psychological symptoms, often co-occurring. Biologic and psychological factors may link symptoms within clusters, distinguishable by prevalence and/or severity. Few studies have examined the effects of behavioral interventions or treatment of symptom clusters.
OBJECTIVES: The aim of this study was to identify symptom clusters among post-treatment BCS and determine symptom cluster improvement following the Mindfulness-Based Stress Reduction for Breast Cancer (MBSR(BC)) program.
METHODS: Three hundred twenty-two Stage 0-III post-treatment BCS were randomly assigned to either a six-week MBSR(BC) program or usual care. Psychological (depression, anxiety, stress, and fear of recurrence), physical (fatigue, pain, sleep, and drowsiness), and cognitive symptoms and quality of life were assessed at baseline, six, and 12 weeks, along with demographic and clinical history data at baseline. A three-step analytic process included the error-accounting models of factor analysis and structural equation modeling.
RESULTS: Four symptom clusters emerged at baseline: pain, psychological, fatigue, and cognitive. From baseline to six weeks, the model demonstrated evidence of MBSR(BC) effectiveness in both the psychological (anxiety, depression, perceived stress and QOL, emotional well-being) (P = 0.007) and fatigue (fatigue, sleep, and drowsiness) (P < 0.001) clusters. Results between six and 12 weeks showed sustained effects, but further improvement was not observed.
CONCLUSION: Our results provide clinical effectiveness evidence that MBSR(BC) works to improve symptom clusters, particularly for psychological and fatigue symptom clusters, with the greatest improvement occurring during the six-week program with sustained effects for several weeks after MBSR(BC) training. TRIAL REGISTRATION: Name and URL of Registry: ClinicalTrials.gov. Registration number: NCT01177124.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  Breast cancer; Mindfulness-Based Stress Reduction (MBSR); physical symptoms; post-treatment; psychological symptoms; symptom cluster

Mesh:

Year:  2016        PMID: 27720794     DOI: 10.1016/j.jpainsymman.2016.08.005

Source DB:  PubMed          Journal:  J Pain Symptom Manage        ISSN: 0885-3924            Impact factor:   3.612


  33 in total

1.  Associations Between Perceived Stress and Chemotherapy-Induced Peripheral Neuropathy and Otoxicity in Adult Cancer Survivors.

Authors:  Christine Miaskowski; Steven M Paul; Judy Mastick; Gary Abrams; Kimberly Topp; Betty Smoot; Kord M Kober; Margaret Chesney; Melissa Mazor; Grace Mausisa; Mark Schumacher; Yvette P Conley; Jennifer Henderson Sabes; Steven Cheung; Margaret Wallhagen; Jon D Levine
Journal:  J Pain Symptom Manage       Date:  2018-03-07       Impact factor: 3.612

2.  Phenotypic Characterization of Paclitaxel-Induced Peripheral Neuropathy in Cancer Survivors.

Authors:  Kord M Kober; Melissa Mazor; Gary Abrams; Adam Olshen; Yvette P Conley; Marilyn Hammer; Mark Schumacher; Margaret Chesney; Betty Smoot; Judy Mastick; Steven M Paul; Jon D Levine; Christine Miaskowski
Journal:  J Pain Symptom Manage       Date:  2018-08-30       Impact factor: 3.612

3.  Differences in symptom clusters before and twelve months after breast cancer surgery.

Authors:  Melissa Mazor; Janine K Cataldo; Kathryn Lee; Anand Dhruva; Bruce Cooper; Steven M Paul; Kimberly Topp; Betty J Smoot; Laura B Dunn; Jon D Levine; Yvette P Conley; Christine Miaskowski
Journal:  Eur J Oncol Nurs       Date:  2017-12-19       Impact factor: 2.398

4.  Effects of Mindfulness-Based Therapy for Cancer Patients: A Systematic Review and Meta-analysis.

Authors:  Li-Ying Lin; Li-Hua Lin; Ghao-Ling Tzeng; Ya-Hui Huang; Jui-Fen Tai; Yu-Ling Chen; Chia-Jung Wu; Pin-Hsi Chen; Pei-Chin Lin; Pi-Lien Hung
Journal:  J Clin Psychol Med Settings       Date:  2022-03-06

5.  The influence of predictive nursing on the emotions and self-management abilities of post-colostomy rectal cancer patients.

Authors:  Li Li; Lingling Liu; Huiling Kang; Lan Zhang
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

Review 6.  Anxiety and Depression in Cancer Survivors.

Authors:  Jean C Yi; Karen L Syrjala
Journal:  Med Clin North Am       Date:  2017-08-18       Impact factor: 5.456

7.  Profiles of depressive symptoms and the association with anxiety and quality of life in breast cancer survivors: a latent profile analysis.

Authors:  Eun-Jung Shim; Donghee Jeong; Hyeong-Gon Moon; Dong-Young Noh; So-Youn Jung; Eunsook Lee; Zisun Kim; Hyun Jo Youn; Jihyoung Cho; Jung Eun Lee
Journal:  Qual Life Res       Date:  2019-10-18       Impact factor: 4.147

8.  Mindfulness-based stress reduction for breast cancer survivors (MBSR(BC)): evaluating mediators of psychological and physical outcomes in a large randomized controlled trial.

Authors:  Cecile A Lengacher; L Forest Gruss; Kevin E Kip; Richard R Reich; Katterine G Chauca; Manolete S Moscoso; Anisha Joshi; Sara Tinsley; Budhrani Shani; Lakeshia Cousin; Carly Paterson Khan; Matthew Goodman; Jong Y Park
Journal:  J Behav Med       Date:  2021-05-07

9.  Mindfulness-based stress reduction for women diagnosed with breast cancer.

Authors:  Lisa K Schell; Ina Monsef; Achim Wöckel; Nicole Skoetz
Journal:  Cochrane Database Syst Rev       Date:  2019-03-27

10.  The Benefit of Enhanced Daycare of Traditional Chinese Medicine for Cancer Treatment Related Adverse Events: A Retrospective Study of Medical Records.

Authors:  Hsiu-An Wu; Chien-Hung Chen; Ming-Hsien Hsieh; Yung-Chang Wu; Jung-Peng Chiu; Chien-Jung Huang; Chung-Hua Hsu
Journal:  Integr Cancer Ther       Date:  2021 Jan-Dec       Impact factor: 3.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.